Vivos Therapeutics VVOS

NASDAQ VVOS
$0.28 -0.02 (-6.29%)
At close: Aug 19, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap4.32 Mn
P/E-0.17
P/S0.22
Div. Yield0.00
Total Debt (Qtr)7.72 Mn
Revenue Growth (1y) (Qtr)70.46
Add ratio to table…

About

Vivos Therapeutics Inc is a revenue stage medical technology and healthcare services company that offers a comprehensive suite of proprietary oral appliances and therapeutic treatments known as the Vivos Method. The Vivos Method non surgically treats maxillofacial and developmental abnormalities of the mouth and jaws that are linked to breathing and sleep disorders such as obstructive sleep apnea and snoring in adults. The company also provides diagnostic and treatment…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue is derived from medical technology (FDA-cleared oral appliances) and healthcare services (diagnostic and treatment services at Sleep and Airway Medicine Centers). It specifically targets the treatment of obstructive sleep apnea and snoring, fitting squarely within the Medical Devices and Healthcare Services industries. Industries: Dental Healthcare Primary Vivos Therapeutics sells proprietary oral appliances (such as Versa, Vida, and Tooth Positioners) and operates dental service organizations to treat maxillofacial abnormalities. Its core product is a non-surgical dental-based therapy for obstructive sleep apnea and snoring. Healthcare Services Healthcare Secondary The company operates Sleep and Airway Medicine Centers that provide diagnostic and treatment services, including sleep testing, and manages sleep medical practices via management services organizations. Diagnostic Equipment Healthcare Secondary Vivos generates revenue from leasing SleepImage home sleep test recorders, which are diagnostic equipment used to identify sleep disorders. Classified using BQ-MICS CIK: 0001716166

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories 196.58 Bn36.244.2232.61 Bn
2 SYK Stryker Corp 127.35 Bn34.154.9314.94 Bn
3 MDT Medtronic plc 118.25 Bn24.443.2527.96 Bn
4 BSX Boston Scientific Corp 74.32 Bn20.223.5412.62 Bn
5 EW Edwards Lifesciences Corp 52.61 Bn2,104.558.080.60 Bn
6 DXCM Dexcom Inc 34.26 Bn34.276.90-
7 GEHC GE HealthCare Technologies Inc. 32.92 Bn16.051.5510.10 Bn
8 SNN Smith & Nephew Plc 26.16 Bn156.664.313.21 Bn